The order followed a plea by the company this week that NCDRC did not have jurisdiction to hear the government's Rs 640-crore class action suit against it after the Bombay High Court had already pronounced a verdict in the matter. Nestle contended that this amounted to judicial indiscipline.
Read more from our special coverage on "NESTLE MAGGI CONTROVERSY"
In its August 13 order, the Bombay High Court had lifted the ban on Maggi noodles, directing Nestle to prove within six weeks that the product was safe. It had said re-testing would be undertaken at three independent laboratories in Mohali, Hyderabad and Jaipur. The three laboratories, the court had said, were accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
In its appeal filed in the Supreme Court, Nestle also said the 16 additional samples of Maggi that were to be tested at a food inspection lab in Chennai should instead be undertaken at the NABL-accredited CFTRI in Mysuru.
On December 10, NCDRC had directed the government to undertake the tests at the Chennai lab, which Nestle had vehemently contested, saying it was not equipped to conduct tests that determined the amount of lead in the product.
A bench comprising Justices Dipak Misra and P C Pant on Wednesday accepted Nestle's plea and directed reports of the test in addition to an earlier one ordered on October 15 be placed before it.
The next hearing on the matter has been posted for January 13, which is also when the Supreme Court will hear an appeal filed by the Food Safety and Standards Authority of India (FSSAI) against the August 13 order of the Bombay High Court.
Last week, the apex court had sought a response from Nestle to FSSAI's plea that the purpose of testing any product was vitiated under the Food Safety and Standards Act, 2006, if the manufacturer was allowed to choose samples of the product to be given for testing.
A Nestle India spokesperson had said last week that it would comply with the Supreme Court's notice. With regard to Wednesday's developments, the company said it was awaiting the formal order on the matter.
The company said it had conducted 3,500 tests representing over 200 million packs in both national and international accredited laboratories and all reports were clear.
In addition to these, various countries, including the US, the UK, Singapore, Australia and others found Maggi noodles exported from India to be safe for consumption.
The company also reiterated reports from the three accredited laboratories mandated by the Bombay High Court to test the samples had also validated that lead present was below the permissible limit.
| NOODLE SAGA |
|
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)